2023
DOI: 10.1101/2023.10.27.564385
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Pitfalls in performing genome-wide association studies on ratio traits

Zachary R McCaw,
Rounak Dey,
Hari Somineni
et al.

Abstract: Genome-wide association studies (GWAS) are often performed on ratios composed of a numerator trait divided by a denominator trait. Examples include body mass index (BMI) and the waist-to-hip ratio, among many others. Explicitly or implicitly, the goal of forming the ratio is typically to adjust the numerator for the denominator. While forming ratios may be clinically expedient, there are several important issues with performing GWAS on ratios. Forming a ratio does not “adjust” for the denominator in the sense … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 72 publications
0
4
0
Order By: Relevance
“…We included height as a covariate to directly adjust for differences in body size between individuals and focus on skeletal proportions instead of overall length. We also adjusted for body size differences in two other ways: dividing each phenotype by height to generate a skeletal proportion, and including a leave one- chromosome-out polygenic risk score (PRS) for height as a covariate in the GWAS ( 43 ). GWAS effect sizes using either height as a covariate or height combined with the one-chromosome-out PRS as a covariate were highly correlated (Pearson correlation = 0.99) ( Methods : Adjusting for height correlation in GWAS by adding height as covariate , Fig.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…We included height as a covariate to directly adjust for differences in body size between individuals and focus on skeletal proportions instead of overall length. We also adjusted for body size differences in two other ways: dividing each phenotype by height to generate a skeletal proportion, and including a leave one- chromosome-out polygenic risk score (PRS) for height as a covariate in the GWAS ( 43 ). GWAS effect sizes using either height as a covariate or height combined with the one-chromosome-out PRS as a covariate were highly correlated (Pearson correlation = 0.99) ( Methods : Adjusting for height correlation in GWAS by adding height as covariate , Fig.…”
Section: Resultsmentioning
confidence: 99%
“…A major issue in carrying out GWAS for phenotypes such as ours where we would like to control for height is the potential for confounding due to the adjustment. McCaw et al highlight the pitfalls in GWAS of ratio traits and describe ways to reduce this confounding ( 43 ). Following their pipeline, we carried out GWAS, adjusting not only for height but also for leave-one-chromosome-out (LOCO) polygenic scores (PGS) of height.…”
Section: Methodsmentioning
confidence: 99%
“…Therefore, we performed principal component analysis (PCA) on the metabolites dataset and used all principal components (PCs; same number as the number of metabolites) as inputs to our ML model (described below). We also included age, sex, and body mass index (BMI) terms - weight (in kilograms), inverse of height (in meters), and inverse of height squared - due to the potential for biased effect estimates from the inclusion of ratio covariates 29 , as inputs to our model.…”
Section: Methodsmentioning
confidence: 99%
“…The lower levels of CRP relative to fibrinogen and D-dimer may relate to other processes, such as less detection by individuals of symptoms of infection, and thus, a lower relative CRP as a denominator in their 2 measures could relate to greater or lesser detection or recognition of symptoms. Problems of using ratio traits have recently been discussed elsewhere [ 9 ].…”
Section: Study Relating Theory Of Pcc Prothrombosis and Pcc Symptomsmentioning
confidence: 99%